Cardiometabolic and Mental Health in Women With Early Gestational Diabetes Mellitus: A Prospective Cohort Study

Abstract

Context Early diagnosis and treatment of gestational diabetes (GDM) may reduce adverse obstetric and neonatal outcomes, especially in high-risk women. However, there is a lack of data for other outcomes. Objective We compared cardiometabolic and mental health outcomes in women with early (eGDM) and classical (cGDM) GDM. Methods This prospective cohort included 1185 All women with cGDM and 76 women with eGDM. The eGDM group had GDM risk factors (BMI >30 kg/m2, family history of diabetes, history of GDM, ethnicity), were tested at <20 weeks gestational age, and diagnosed using American Diabetes Association prediabetes criteria. All women underwent lifestyle adaptations. Obstetric, neonatal, mental, and cardiometabolic outcomes were assessed during pregnancy and postpartum. Results The eGDM group had lower gestational weight gain than cGDM (10.7 ± 6.2 vs 12.6 ± 6.4; P = 0.03) but needed more medical treatment (66% vs 42%; P < 0.001). They had similar rates of adverse maternal and neonatal outcomes, except for increased large-for-gestational-age infants (25% vs 15%; P = 0.02). Mental health during pregnancy and postpartum did not differ between groups. eGDM had more atherogenic postpartum lipid profile than cGDM (P ≤ 0.001). In eGDM, the postpartum prevalence of the metabolic syndrome (MetS) was 1.8-fold, prediabetes was 3.1-fold, and diabetes was 7.4-fold higher than cGDM (waist circumference-based MetS: 62% vs 34%/BMI-based MetS: 46% vs 24%; prediabetes: 47.5% vs 15.3%; diabetes: 11.9% vs 1.6%, all P < 0.001). These differences remained unchanged after adjusting for GDM risk factors. Conclusion Compared with cGDM, eGDM was not associated with differences in mental health, but with increased adverse cardiometabolic outcomes, independent of GDM risk factors and gestational weight gain. This hints to a preexisting risk profile in eGDM.

Reactive hypoglycaemia during the OGTT after gestational diabetes mellitus: Metabolic implications and evolution

“…This prospective clinical cohort consecutively followed women with GDM during pregnancy up to 1‐year postpartum between 2011 and 2021 18 , 19 , 20 at the Lausanne University Hospital in Switzerland. The Lausanne University Hospital is affiliated to the University of Lausanne and is a tertiary hospital and referral centre in the Vaud province in Switzerland.…”

Cardio-Metabolic and Mental Health Outcomes Before and During the COVID-19 Pandemic in a Cohort of Women With Gestational Diabetes Mellitus in Switzerland

“…Details regarding this longitudinal clinical cohort following women with GDM during pregnancy and in the postpartum have been previously described (28)(29)(30)(31)(32). This cohort investigates lifestyle factors and metabolic consequences of GDM on maternal health and the mother-child relationship during pregnancy up to three years postpartum.…”

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement

“…diabetesatlas.org/). Diabetes is classified into four types: type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM), and monogenic diabetes mellitus (1)(2)(3)(4)(5). T1DM is an autoimmune disease, where autoreactive T cells attack pancreatic b-cells, leading to insulitisrelated islet b-cell destruction, which results in an absolute lack of insulin secretion causing hyperglycemia, abnormal glucose metabolism, and lifelong dependence on exogenous insulin.…”